Objective To investigate the clinical utility of CO2 gas as an arteria
l contrast agent, the experience with CO2 arteriography at the Univers
ity of Florida was reviewed. Summary Background Data Preliminary studi
es have demonstrated the feasibility of CO2 arteriography and shown th
at arterial injection of CO2 gas appears non-toxic (which could limit
the risks of contrast induced renal injury and allergic reaction). How
ever, numerous technical problems make CO2 arteriography a demanding t
echnique and recent studies have suggested that distal lower extremity
vessels are difficult to image using CO2 arteriography, especially wh
en significant arterial occlusive disease is present. Methods One hund
red twenty-eight CO2 arteriograms done in 115 patients were reviewed.
CO2 arteriograms were graded as excellent, good, poor, or inadequate b
y two blinded observers and results of CO2 studies compared to results
of standard contrast studies (done in 98 patients for image compariso
n). In addition, a therapeutic plan based on the CO2 arteriograms was
compared with the therapy each patient received. Results One hundred-s
eventeen (91%) of the CO2 arteriograms were of good or excellent quali
ty and agreement between CO2 Studies and standard contrast studies was
seen in 93 of 98 cases (95%). Accurate therapeutic plans based on CO2
studies were possible in 92% of cases with inadequate visualization o
f infrapopliteal arteries being the major limitation (7 cases). No all
ergic reactions occurred and only one patient potentially had contrast
-induced nephrotoxicity. Conclusions CO2 arteriography provides accura
te, clinically useful arterial imaging with minimal risk. Thus, this n
ew technology significantly increases the utility of arteriography in
patients with peripheral vascular disease.